venetoclax
Venetoclax is a drug used to treat Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and other conditions. Venetoclax is being actively studied in 234 studies and prior, has been studied in 25.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
AbbVie | M D Anderson Cancer Center | Matthew S. Davids, MD |
M.D. Anderson Cancer Center | MD Anderson Cancer Center | Paolo Ghia |
Hoffmann-La Roche | Dana Farber Cancer Institute | Andrew Lane |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021U
N
Recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
- Taipei, TaiwanNational Taiwan University Hospital
2021-10-27
Oct 27, 2021D
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
- Boston, MassachusettsDana-Farber Cancer Institute
2021-09-08
Sep 8, 2021N
Not yet recruiting
- Acute Myeloid Leukemia
- siremadlin
- +2 more
- (no location specified)
2022-03-29
Mar 29, 2022D
Active, not recruiting
- Waldenstrom Macroglobulinemia
- MYD88 Gene Mutation
- IBRUTINIB
- Venetoclax
- Boston, Massachusetts
- +1 more
2022-04-01
Apr 1, 2022A
Available
- Chronic Lymphocytic Leukemia (CLL)
- +6 more
- Venetoclax
- (no location specified)
2022-03-28
Mar 28, 2022M
U
Recruiting
- Acute Myeloid Leukemia
- Azacitidine
- Venetoclax
- Aurora, ColoradoUniverstiy of Colorado Hospital
2022-02-15
Feb 15, 2022C
Recruiting
- AML, Adult
- Chemotherapy Effect
- Venetoclax
- +3 more
- Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
2022-02-28
Feb 28, 2022M
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Venetoclax
- +5 more
- (no location specified)
2022-03-30
Mar 30, 2022U
Recruiting
- Chronic Lymphocytic Leukemia
- Cirmtuzumab
- Venetoclax
- San Diego, CaliforniaUCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021C
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Decitabine
- +2 more
- Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
2022-02-08
Feb 8, 2022L
Not yet recruiting
- Acute Myeloid Leukemia
- Fludarabine
- +4 more
- (no location specified)
2022-03-04
Mar 4, 2022P
Recruiting
- Breast Neoplasm Female
- Venetoclax
- +2 more
- Melbourne, Victoria, Australia
- +2 more
2022-03-10
Mar 10, 2022K
Terminated
- Primary CNS Lymphoma
- Venetoclax
- Obinutuzumab
- Stuttgart, Baden-Württemberg, GermanyKlinikum Stuttgart
2022-01-18
Jan 18, 2022K
Withdrawn
- Chronic Lymphocytic Leukemia
- Loss of Chromosome 17p
- Ibrutinib
- Venetoclax
- (no location specified)
2021-10-29
Oct 29, 2021C
Suspended
- Leukemia
- Vyxeos
- Venetoclax
- Cincinnati, OhioCincinnati Children's Hospital Medical Center
2021-12-29
Dec 29, 2021J
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- Small Lymphocytic Lymphoma
- Venetoclax
- Zanubrutinib
- Boston, Massachusetts
- +2 more
2022-03-16
Mar 16, 2022D
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
- Boston, MassachusettsDana Farber Cancer Institute
2021-11-02
Nov 2, 2021U
Not yet recruiting
- Myeloproliferative Neoplasm
- BCR-ABL Negative
- Azacitidine
- Venetoclax
- Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
2021-09-29
Sep 29, 2021M
Withdrawn
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Eprenetapopt
- Venetoclax
- Houston, TexasM D Anderson Cancer Center
2022-02-23
Feb 23, 2022D
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Copanlisib
- Venetoclax
- Boston, MassachusettsDana-Farber Cancer Institute
2021-09-08
Sep 8, 2021M
Not yet recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- Venetoclax
- Houston, TexasM D Anderson Cancer Center
2022-04-07
Apr 7, 2022D
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- Venetoclax
- +2 more
- Boston, Massachusetts
- +1 more
2021-10-19
Oct 19, 2021